Skip to main content
Download PDF

Cervical stump leiomyomata after supracervical hysterectomy; a case report with review of literature

BMC Women's Health volume 24, Article number: 500 (2024) Cite this article

Abstract

Background

Despite being a highly debated issue, subtotal or supracervical hysterectomy (SCH) is still considered a safe and effective treatment for women with benign gynecological lesions. Benign and malignant cervical diseases have been reported after SCH, with fibroids being the most frequently diagnosed lesions in the excised cervical stump. Recurrence of cervical disease after SCH usually presents with vaginal bleeding, pelvic mass, or abdominal pain; moreover, it may necessitate reoperation and resection of the cervical stump or trachelectomy. Trachelectomy is known to be a difficult surgical procedure that may be associated with significant intra- and post-operative morbidity.

Case presentation

We presented here a case of a 41-year-old nulliparous woman with a pelvic mass related to the cervical stump presented 2 years after subtotal hysterectomy, performed due to interactable abnormal uterine bleeding, which was attributed to a multiple fibroid uterus. Six years ago, she complained of pelvic pain, excessive vaginal discharge, and spotting. A transvaginal sonography and magnetic resonance imaging with contrast were performed, which revealed a 10.2 × 7.6 × 6.5 cm heterogeneous pelvic mass with irregular borders and marked vascularity on color Doppler. Surgical exploration and resection of the mass with cervical stump excision were performed. Histopathology confirmed the diagnosis of cervical stump multiple benign leiomyomata with no atypical features.

Conclusion

Recurrence or De novo development of leiomyomata and other cervical lesions might occur after supracervical or subtotal hysterectomy; thus, thorough pre-operative counseling for women requesting a SCH regarding the pros and cons of the procedure compared with total hysterectomy should be optimized. Meticulous follow-up, including the continuation of routine cervical cytological smears, is mandatory for patients with a retained cervix.

Peer Review reports

Background

Hysterectomy is the most frequently performed surgical procedure for women with symptomatic uterine fibroids [1, 2].

Preservation of the cervix uteri during a hysterectomy is a highly debated issue. Some of the potential benefits of supracervical hysterectomy (SCH) that proponents often mention are reduced blood loss, a shorter hospital stay, fewer intraoperative risks, fewer urinary complications, and better pelvic support [3,4,5]. Although postoperative sexual function is presumed to be more satisfactory after SCH [6], it was not found to be superior to a total hysterectomy (TH) [7]. On the contrary, some problems have been often described with SCH, such as cyclic bleeding, pelvic pain, and a higher incidence of cervical disease [8]. Among the commonest clinical indications for surgical excision of the cervical stump following supracervical hysterectomy are pelvic masses and vaginal bleeding [9]. It has been observed that fibroids are the most common (in approximately 35%) pathology found in the excised cervical stump [10].

We report a case of large stump fibroids after a subtotal abdominal hysterectomy for multiple fibroid uterus.

Case report

Chief complaints

A 41-year-old nulliparous woman presented to the gynecology outpatient clinic of El-Shatby University Hospital, Alexandria, Egypt, with pelvic pain and excessive vaginal discharge with occasional vaginal spotting.

History of the current illness

The patient had chronic dull, aching pelvic pain with a heaviness sensation. She also described an increased amount of brownish vaginal discharge. Her symptoms started in 2018, and she reported that the condition became noticeably worse six months ago with frequent episodes of vaginal bleeding, so she sought gynecological consultation.

History of the past illness

She gave a history of four abdominal myomectomies for the excision of multiple fibroids while she was seeking fertility; the last myomectomy was performed in 2014. After that, she complained of intractable vaginal bleeding. A multiple fibroid uterus was diagnosed, so she underwent a supracervical abdominal hysterectomy with preservation of both ovaries in 2016. All previous surgeries were performed outside our hospital through midline vertical incisions.

Hysterectomy specimen examination revealed a 2500-gm uterus with multiple interstitial and subserous leiomyomata ranging from 2 to 9.5 cm. Histopathological examination confirmed the diagnosis of typical leiomyoma pathological features with no detected atypical or mitotic figures.

Medical, personal, and family history

She gave history of two failed IVF trials after her first and third myomectomy. Her medical history is irrelevant except for mild bronchial asthma controlled with periodic beta-agonist inhalers. She did not have a history of smoking or drinking alcohol. She did not undergo any pap smears either before or after the supracervical hysterectomy. She denies any follow-up visits to her gynecologist after the hysterectomy.

Physical examination

On examination, her abdomen was lax and non-tender, with no palpable masses. The previous midline incisions were noticed with no palpable hernias. A bimanual examination revealed a firm, non-tender pelvic mass that has limited mobility in conjugation with movement of the cervix. A speculum examination showed a normal-looking cervix with a well-estrogenized vagina.

Imaging examinations

A transvaginal ultrasound revealed a 10.2 × 7.6 × 6.5 cm pelvic mass with irregular borders and heterogeneous echotexture with no external shadowing. There were internal cystic areas resembling the picture of degenerated fibroid. The mass had marked vascularity on the color Doppler, especially in the peripheral regions. The mass was seen encroaching on the right adnexa, with the normal appearance of the left ovary.

The mass looks suspicious for malignancy, so confirmatory magnetic resonance imaging (MRI) with IV gadolinium contrast was performed, as demonstrated in Figs. 1 and 2. The heterogeneous T2 lobulated mixed solid and cystic lesion showed a mainly hypo-intense signal in the T2 and T1 weighted images, epicentered upon the cervical stump and engulfing the right adnexa.

The patient was counseled for exploratory laparotomy and resection of the mass with the cervix and both ovaries. A complete preoperative workup was performed, including a chest x-ray; all investigations were within normal range.

Fig. 1
figure 1

Sagittal T2W image showing the remaining cervical stump with its endometrial lining (blue arrow) and a heterogeneous solid lesion (yellow star) above the cervix with its MRI signal matching with fibroid

Full size image
Fig. 2
figure 2

Sagittal T2W image showing heterogeneous lobulated mainly hypo-intense solid (blue arrows) lesion showing areas of cystic changes (small yellow arrows) consistent with degenerated cervical leiomyomata

Full size image

Surgical details

An extended lower midline incision was performed to optimize the exposure of the entire abdominal cavity and the pelvis. Upon entry of the abdomen, a large pelvi-abdominal mass was found, which was entirely covered by densely adherent bowel loops posteriorly and an exceptionally adherent urinary bladder anteriorly.

The lateral approach, through opening the retroperitoneal avascular pelvic spaces, was used to properly identify the borders of the mass and to secure the important adjacent structures, namely the ureters, iliac vessels, and recto sigmoid.

Creation of the para-vesical and para-rectal spaces was performed bilaterally, which facilitated the identification of the ureters and iliac vessels, followed by ureterolysis and lateralization of both ureters. Dissection of the densely adherent recto-sigmoid off the back of the mass with development of the rectovaginal space and identification of uterosacral ligaments was done.

A decision was made to excise the fibroids from the cervical stump to optimize the exposure of the stump and allow a safe stumpectomy procedure (Fig. 3).

Excision of the cervical stump using the retrograde colpotomy approach was utilized for the preservation of maximal vaginal length. Then, suturing of the vaginal cuff with a single layer of continuous absorbable sutures was done. She did not require a blood transfusion intraoperatively.

Fig. 3
figure 3

The surgical specimen showing multiple leiomyomata and the excised cervical stump

Full size image

Postoperative course and follow-up

The patient’s postoperative course was uneventful. Her postoperative hemoglobin was 8.1 g/dl. A transfusion of two units of packed RBCs was performed, and she was discharged on the 5th postoperative day after regular bowel movements were returned and her hemoglobin level was 9.6 g/dl. Histopathological examination of the specimen confirmed the diagnosis of multiple benign leiomyomata of the cervical stump with marked hyaline, mucoid, and cystic degeneration with no atypical features.

Discussion

One of the simplest and most successful treatments for benign uterine disorders such as fibroids, adenomyosis, and functional uterine bleeding is hysterectomy.

Route of hysterectomy

Hysterectomies could be performed through minimally invasive approaches such as vaginal or laparoscopic (with or without robotic assistance) approaches or through an abdominal approach. Various factors could influence the selection of a certain route of hysterectomy, such as the size and shape of the uterus and vagina, the degree of extrauterine disease, the need for concurrent procedures, the surgeon’s training and experience, the average case volume, the hospital’s technology, devices, and support, the urgency or scheduling of the case, and the patient’s preference [11]. When possible, minimally invasive hysterectomy techniques (laparoscopic or vaginal, including robot-assisted laparoscopy) should be used due to their established benefits over abdominal hysterectomy.

Among the minimally invasive approaches, ACOG and SOGC recommend the vaginal method, as it was found to be associated with a faster return to normal activities and a better quality of life. Compared with laparoscopic hysterectomy, vaginal hysterectomy is also associated with a shorter operating time and hospital stay [12, 13].

Nevertheless, as per the guidelines and recommendations of the German, Austrian, and Swiss societies of gynecology and obstetrics (DGGG, OEGGG, and SGGG), patients should be given the ability to select the most appropriate therapeutic intervention for their benign uterine disease, considering their individual circumstances [14].

Total versus subtotal hysterectomy

Based on the extent of the surgery, hysterectomy could be classified into two categories: total hysterectomy (TH), which entails excision of the uterine body and the cervix, and subtotal or supracervical hysterectomy (SH), which describes removal of the uterine body with cervical stump preservation [15].

Before the era of readily available antibiotics and blood transfusions, SCH was much preferred to TH, as it was reported that TH was associated with a significantly higher complication rate, including mortality. At this time, the risk of death for a subtotal hysterectomy performed for fibroids was 1-2.5%, whereas the risk of death for TH performed for benign pathologies including endometriosis and tubo-ovarian abscesses was 3-6.5% [16].

For the following 3 decades, there was a remarkable shift towards total hysterectomies, with the prevalence of SH being approximately 1% of all hysterectomies [6]. The few remaining SH were likely to be conducted when the patient had co-morbidities that necessitated a shorter, less risky procedure, or when the surgeon encountered distorted pelvic anatomy or operative difficulties.

After that, in the late 1990s, subtotal/supracervical hysterectomy regained its popularity, especially due to the introduction of minimally invasive or laparoscopic approaches [17]. It was proposed that this was because SH is simpler to execute during a laparoscopy and because the consensus is that SH would have no or minimal effects on the nerves, vessels, and other pelvic structures, leading to better results in terms of urinary symptoms, pelvic support, and patients’ quality of life [18]. Since then, the merits and drawbacks of subtotal vs. total hysterectomy procedures have been addressed in numerous RCTs, meta-analyses, and Cochrane databases.

Moreover, among the indications of performing a SCH is pelvic organ prolapse (POP). Mesh erosion, a known consequence of mesh sacrocolpopexy following total hysterectomy, could be prevented with laparoscopic sacrocervicopexy, which has been shown to be an effective choice for the management of POP with an excellent safety profile [4, 19, 20].

Despite the historical claims that SH is associated with lower urinary tract complications, better sexual outcomes, and fewer pelvic floor symptoms compared to TH, supracervical hysterectomy has been usually criticized for the high possibility of postoperative long-term sequalae such as cervical dysplasia and carcinoma, cyclic vaginal bleeding, pelvic pain, vaginal discharge, cervical prolapse, and recurrence or de novo development of uterine disorders. Also, there is a significant risk of perioperative bleeding, urinary tract injuries, and gastrointestinal tract injuries in a subsequent extirpation of the cervical stump [10].

Risk of CIN and cervical carcinoma after SCH

The overall reported risk of cervical stump carcinoma is low; it was reported to be 1–3% of all women who underwent SH, and it represents approximately 3–9% of all cervical malignancies [21]. In a multicenter study on 903 women, only 3 cases (0.33%) of cervical stump carcinoma were observed [22]. It was found that most women undergoing SH are unaware of the recommendations for cervical screening after the hysterectomy [23].

In one survey of women who had minimally invasive hysterectomies, only 67% of women were able to correctly report if the cervix was removed during surgery and the need for future cervical screening as per recommendations [24]. This finding raises the concern that, before offering the option of subtotal hysterectomy, eligible women must be counseled about the importance of continuing their cervical screening program as per guidelines. Furthermore, SH should not be advised for women who have abnormal PAP smears or high-risk HPV infections, as these conditions increase the chance of developing cervical cancer. Historically, it was thought that electrocoagulation of the cervical mucosa during SH might reduce cervical stump carcinoma besides preventing cyclic bleeding after the procedure [25].

SOGC recommends the continuation of routine cervical screening for women with SH as women with an intact uterus. It is also recommended that women with a current or significant history of abnormal cervical cytological smears be informed about the advantages of vaginal or total hysterectomy over SH [26].

Cyclic vaginal bleeding after SCH

Women undergoing SH are prone to experiencing vaginal bleeding from the retained cervix, which may be persistent and cyclic in some cases. In most cases, this bleeding is minimal, tolerable, and self-limited, especially in well-counselored women [27, 28]. The reported incidence of postoperative bleeding after SH varies between numerous studies, being as low as 0.9% or as high as 25% [29,30,31,32,33,34,35], with the majority of studies reporting rates between 5 and 10% [36]. This difference in reported rates might be attributed to the fact that some studies report only cyclic bleeding and others document any form of postoperative bleeding [27]. However, it was found that only half of women undergoing SH were aware that they could suffer from this postoperative bleeding [37].

The available literature is conflicting regarding the risk factors for cyclic bleeding following SH. Heavy menstrual bleeding before hysterectomy was identified as a significant risk factor in one study [37]. While endometriosis was found to be significantly associated with postoperative bleeding in some studies [17, 28,29,30,31,32,33,34,35,36,37,38], others failed to identify a correlation between endometriosis and this bleeding [27].

There are many factors that have been reported to prevent postoperative bleeding after SH, such as older age [37], postmenopausal state [28], and bilateral oophorectomy during the hysterectomy [27]. Moreover, the removal or fulguration of the endocervix during the hysterectomy has been thoroughly studied with inconsistent conclusions [35, 37, 39].

Recurrence or De novo development of uterine diseases after SCH

Cervical stump leiomyomata, cervical stump cysts, endometriosis, adenomyosis, or cervical stump prolapse are among the comorbidities that may arise or recur in the retained cervix after SH [40]. Additionally, leiomyosarcoma is an extremely rare lesion that may arise in the cervical stump following a SH [41]. It is noteworthy that using power morcellation during laparoscopic supracervical hysterectomy (LSCH) might increase the frequency of recurring fibroids, endometriosis, and adenomyosis [42].

Fibroids have always been described as a “recurring disease.” After myomectomy, there are variable reported rates of recurrence, including 12–15%, 31–43%, 51–62%, and 84% at 1, 3, 5, and 8 years, respectively [43,44,45,46,47,48,49,50], and approximately10–20% of cases will undergo a hysterectomy within 5–10 years of myomectomy [49, 51].

The incidence of fibroids in the retained cervical stump after SCH ranges from 0.6 to 3.7% [9, 52]. In a retrospective analysis of 137 patients who underwent cervical stump resection after SCH, Neis F. et al. reported that 3.7% of these patients have fibroids in their cervical stumps [53]. Similarly, fibroids were found in 2 patients who underwent cervical stumpectomy after SCH in a cohort of 309 patients reported by Hilger et al. [54].

Similar to the case we presented here, recurrence or new development of fibroids over the cervical stump has been described not only after subtotal hysterectomy but also reported after total hysterectomy. Recently, a recurrence of adenomyosis was reported after LSCH with power morcellation [55]. Additionally, benign metastatic leiomyoma (BML) has been described as occurring even after total hysterectomy [56,57,58,59,60].

Among the reported lesions that may arise on top of the retained cervical stump are cervical cysts, which usually result from failure to completely remove all cervical glands. Those cysts are usually benign; however, they may encompass any grade of cervical intraepithelial dysplasia. Initially, cervical cysts may not cause any symptoms. However, persistent cervical cysts may result in a bulging vagina and compression symptoms, including urgency, frequent, and inefficient urination, which may have a major negative impact on the patients’ quality of life. [40, 61].

Table 1. summarizes the reported cases of benign cervical stump lesions reported in the literature. Thirteen cases—in addition to the currently presented case—of histologically proven benign leiomyoma on top of the cervical stump are described. The mean age at presentation is 51 ± 9.36 years, with a mean interval between hysterectomy and symptoms of 7.84 ± 5.8 years. Ten women (71%) had a history of SCH, and four women (29%) had undergone a TH. Preservation of at least one ovary was found in 9/14 (64%) of cases. The indications for the hystectomy were symptomatic fibroids in 10 cases (71%), menorrhagia in 3 cases (21%), and one case of endometriosis (8%). The clinical presentations were pelvic and abdominal pain, vaginal bleeding, and abdominal distention in the majority of cases. One case presented with dysparnia due to a prolapsed fibroid polyp. The mean largest diameter of the excised lesions was 12.4 ± 9.3 cm. Management was achieved via abdominal exploration and excision of the masses with stumpectomy in 9/14 (64%) of the cases; two cases were managed laparoscopically; two cases were managed by vaginal excision of the mass only; and robotically assisted excision of the mass and stumpectomy was performed in one case.

Moreover, cases of malignant leiomyosarcoma, although exceedingly rare, have also been reported after hyetrectomy, with one case from almost 100 years ago, summerized in Table 2 [41, 62, 63].

Nevertheless, patient satisfaction after supracervical hysterectomy was reported to be high [8, 37]. Hence, some patients may elect to have a supracervical hysterectomy even though the evidence shows that there is no clinically significant difference in the rate of complications (such as infection, blood loss, urinary tract, bowel, or vascular injury) and that there is unclear benefit in terms of favorable patient outcomes (such as sexual function, urinary function, or bowel function) between a supracervical hysterectomy and a total hysterectomy. An open abdominal or laparoscopic procedure is most suitable in these circumstances [64]. Therefore, gynecologists should be aware of the advantages and drawbacks of SCH vs. TH, and women requesting a SCH should be properly counseled about the long-term outcomes of the procedure.

Table 1 Reported cases of benign cervical stump lesions after supracervical hysterectomy
Full size table
Table 2 Reported cases of malignant leiomyosarcoma after supracervical hysterectomy
Full size table

Conclusion

Recurrence or De novo development of leiomyomata and other crevical lesions might occur after supracervical or subtotal hysterectomy; thus, thorough pre-operative counseling for women requesting a SCH regarding the pros and cons of the procedure compared with total hysterectomy should be optimized. Meticulous follow-up, including the continuation of routine cervical cytological smears, is mandatory for patients with a retained cervix. We provided a case report of recurrent multiple leiomyomata on top of the cervical stump following a SCH with a comprehensive review of the previously reported cases.

Data availability

All data of this manuscript are available upon reasonable request.

Abbreviations

SCH:

Supracervical Hysterectomy

TH:

Total Hysterectomy

MRI:

Magnetic Resonance Imaging

ACOG:

American College of Obstetrics and Gynecology

SOGC:

Society of Obstetricians and Gynecologists of Canada

CIN:

Cervical Intraepithelial Neoplasia

References

  1. Chu CM, Acholonu UC, Chang-Jackson S-CR, Nezhat FR. Leiomyoma recurrent at the cervical stump: report of two cases. J Minim Invasive Gynecol. 2012;19:131–3. https://doi.org/10.1016/j.jmig.2011.10.006.

    Article  PubMed  Google Scholar 

  2. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, et al. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol. 2008;198. https://doi.org/10.1016/j.ajog.2007.05.039. :34.e1-7.

  3. Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med. 2002;347:1318–25. https://doi.org/10.1056/NEJMoa013336.

    Article  PubMed  Google Scholar 

  4. Dallas K, Taich L, Kuhlmann P, Rogo-Gupta L, Eilber K, Anger JT, et al. Supracervical hysterectomy is protective against Mesh complications after minimally invasive abdominal sacrocolpopexy: a Population-based Cohort Study of 12,189 patients. J Urol. 2022;207:669–76. https://doi.org/10.1097/JU.0000000000002262.

    Article  PubMed  Google Scholar 

  5. Alkatout I, Mazidimoradi A, Günther V, Salehiniya H, Allahqoli L. Total or subtotal hysterectomy for the treatment of endometriosis: a review. J Clin Med. 2023;12. https://doi.org/10.3390/jcm12113697.

  6. Kilkku P, Grönroos M, Hirvonen T, Rauramo L. Supravaginal uterine amputation vs. hysterectomy. Effects on libido and orgasm. Acta Obstet Gynecol Scand. 1983;62:147–52. https://doi.org/10.3109/00016348309155779.

    Article  PubMed  CAS  Google Scholar 

  7. Dedden SJ, Werner MA, Steinweg J, Lissenberg-Witte BI, Huirne JAF, Geomini PMAJ, et al. Hysterectomy and sexual function: a systematic review and meta-analysis. J Sex Med. 2023;20:447–66. https://doi.org/10.1093/jsxmed/qdac051.

    Article  PubMed  Google Scholar 

  8. Lieng M, Lømo AB, Qvigstad E. Long-term outcomes following laparoscopic and abdominal supracervical hysterectomies. Obstet Gynecol Int. 2010;2010:989127. https://doi.org/10.1155/2010/989127.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kho RM, Magrina JF. Removal of the retained cervical stump after supracervical hysterectomy. Best Pract Res Clin Obstet Gynaecol. 2011;25:153–6. https://doi.org/10.1016/j.bpobgyn.2010.10.007.

    Article  PubMed  Google Scholar 

  10. McHale MP, Smith AJB, Fader AN, Wethington SL. Outcomes of women undergoing excision of the retained cervix after supracervical hysterectomy. Obstet Gynecol. 2021;137:831–6. https://doi.org/10.1097/AOG.0000000000004360.

    Article  PubMed  CAS  Google Scholar 

  11. Committee opinion 701. Choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2017;129:e155–9. https://doi.org/10.1097/AOG.0000000000002112.

    Article  Google Scholar 

  12. Pickett CM, Seeratan DD, Mol BWJ, Nieboer TE, Johnson N, Bonestroo T, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2023;8:CD003677. https://doi.org/10.1002/14651858.CD003677.pub6.

    Article  PubMed  Google Scholar 

  13. Aarts JWM, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BWJ, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;2015:CD003677. https://doi.org/10.1002/14651858.CD003677.pub5.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Neis KJ, Zubke W, Römer T, Schwerdtfeger K, Schollmeyer T, Rimbach S, et al. Indications and route of hysterectomy for benign diseases. Guideline of the DGGG, OEGGG and SGGG (S3 level, AWMF registry 015/070, April 2015). Geburtshilfe Frauenheilkd. 2016;76:350–64. https://doi.org/10.1055/s-0042-104288.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Sloth SB, Schroll JB, Settnes A, Gimbel H, Rudnicki M, Topsoee MF, et al. Systematic review of the limited evidence for different surgical techniques at benign hysterectomy: a clinical guideline initiated by the Danish Health Authority. Eur J Obstet Gynecol Reprod Biol. 2017;216:169–77. https://doi.org/10.1016/j.ejogrb.2017.07.012.

    Article  PubMed  Google Scholar 

  16. Morrison JK. The ureter and hysterectomy, including the effects of certain gynaecological conditions on the urinary tract. J Obstet Gynaecol Br Emp. 1960;67:66–73.

    Article  PubMed  CAS  Google Scholar 

  17. Okaro EO, Jones KD, Sutton C. Long term outcome following laparoscopic supracervical hysterectomy. BJOG. 2001;108:1017–20. https://doi.org/10.1111/j.1471-0528.2001.00252.x.

    Article  PubMed  CAS  Google Scholar 

  18. Helström L, Bäckström T, Sörbom D, Lundberg PO. Sacral nervous function, hormonal levels and sexuality in premenopausal women before and after hysterectomy. Acta Obstet Gynecol Scand. 1994;73:570–4. https://doi.org/10.3109/00016349409006275.

    Article  PubMed  Google Scholar 

  19. Rosati M, Bramante S, Conti F. A review on the role of laparoscopic sacrocervicopexy. Curr Opin Obstet Gynecol. 2014;26:281–9. https://doi.org/10.1097/GCO.0000000000000079.

    Article  PubMed  Google Scholar 

  20. Rahmanou P, White B, Price N, Jackson S. Laparoscopic hysteropexy: 1- to 4-year follow-up of women postoperatively. Int Urogynecol J. 2014;25:131–8. https://doi.org/10.1007/s00192-013-2209-5.

    Article  PubMed  Google Scholar 

  21. Hellström A-C, Hellman K, Pettersson BF, Andersson S. Carcinoma of the cervical stump: fifty years of experience. Oncol Rep. 2011;25:1651–4. https://doi.org/10.3892/or.2011.1228.

    Article  PubMed  Google Scholar 

  22. Rechberger T, Perzyło K, Miotła P, Nowak-Markwitz E, Zaborowski M, Lemańska A, et al. [Carcinoma of the cervical stump–multicenter study]. Ginekol Pol. 2014;85:435–40. https://doi.org/10.17772/gp/1749.

    Article  PubMed  Google Scholar 

  23. Andrikos D, Andrikos A, Naem A, Ebertz O, Devassy R, De Wilde RL, et al. Advanced cervical stump cancer after laparoscopic subtotal hysterectomy: a case report of imaging, laparoscopic staging and treatment approach. BMC Womens Health. 2023;23:281. https://doi.org/10.1186/s12905-023-02428-7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Mattingly M, Juran R, Su I, Ebinger J, Daggy J, Tucker Edmonds B. Patient knowledge of hysterectomy and pap screening after minimally invasive hysterectomy. Patient Educ Couns. 2017;100:121–5. https://doi.org/10.1016/j.pec.2016.08.017.

    Article  PubMed  Google Scholar 

  25. Kilkku P, Grönroos M. Peroperative electrocoagulation of endocervical mucosa and later carcinoma of the cervical stump. Acta Obstet Gynecol Scand. 1982;61:265–7. https://doi.org/10.3109/00016348209156569.

    Article  PubMed  CAS  Google Scholar 

  26. Kives S, Lefebvre G. 238-Supracervical hysterectomy. J Obstet Gynaecol Can. 2018;40:e597–604. https://doi.org/10.1016/j.jogc.2018.04.033.

    Article  PubMed  Google Scholar 

  27. Ghomi A, Hantes J, Lotze EC. Incidence of cyclical bleeding after laparoscopic supracervical hysterectomy. J Minim Invasive Gynecol. 2005;12:201–5. https://doi.org/10.1016/j.jmig.2005.03.008.

    Article  PubMed  Google Scholar 

  28. Sasaki KJ, Cholkeri-Singh A, Sulo S, Miller CE. Persistent bleeding after laparoscopic supracervical hysterectomy. JSLS 2014;18. https://doi.org/10.4293/JSLS.2014.002064

  29. Morrison JE, Jacobs VR. 437 classic intrafascial supracervical hysterectomies in 8 years. J Am Assoc Gynecol Laparosc. 2001;8:558–67. https://doi.org/10.1016/S1074-3804(05)60621-4.

    Article  PubMed  Google Scholar 

  30. Kim DH, Bae DH, Hur M, Kim SH. Comparison of classic intrafascial supracervical hysterectomy with total laparoscopic and laparoscopic-assisted vaginal hysterectomy. J Am Assoc Gynecol Laparosc. 1998;5:253–60.

    Article  PubMed  CAS  Google Scholar 

  31. Gimbel H, Zobbe V, Andersen BM, Filtenborg T, Gluud C, Tabor A. Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results. BJOG. 2003;110:1088–98.

    PubMed  Google Scholar 

  32. Manyonda I, Thakar RB, Ayers S. Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results. BJOG. 2004;111. https://doi.org/10.1111/j.1471-0528.2004.00164.x. 760; author reply 760-1.

  33. van der Stege JG, van Beek JJ. Problems related to the cervical stump at follow-up in laparoscopic supracervical hysterectomy. JSLS. 1999;3:5–7.

    PubMed  PubMed Central  Google Scholar 

  34. van Wijngaarden WJ, Filshie GM. Laparoscopic supracervical hysterectomy with Filshie clips. J Am Assoc Gynecol Laparosc. 2001;8:137–42. https://doi.org/10.1016/s1074-3804(05)60563-4.

    Article  PubMed  Google Scholar 

  35. Nouri K, Demmel M, Greilberger U, Fischer E-M, Seemann R, Egarter C, et al. Prospective cohort study and meta-analysis of cyclic bleeding after laparoscopic supracervical hysterectomy. Int J Gynaecol Obstet. 2013;122:124–7. https://doi.org/10.1016/j.ijgo.2013.03.021.

    Article  PubMed  Google Scholar 

  36. Jenkins TR. Laparoscopic supracervical hysterectomy. Am J Obstet Gynecol. 2004;191:1875–84. https://doi.org/10.1016/j.ajog.2004.06.096.

    Article  PubMed  Google Scholar 

  37. Lieng M, Qvigstad E, Istre O, Langebrekke A, Ballard K. Long-term outcomes following laparoscopic supracervical hysterectomy. BJOG. 2008;115:1605–10. https://doi.org/10.1111/j.1471-0528.2008.01854.x.

    Article  PubMed  CAS  Google Scholar 

  38. Baker PM, Clement PB, Bell DA, Young RH. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ. Int J Gynecol Pathol. 1999;18:198–205.

    Article  PubMed  CAS  Google Scholar 

  39. Schmidt T, Eren Y, Breidenbach M, Fehr D, Volkmer A, Fleisch M, et al. Modifications of laparoscopic supracervical hysterectomy technique significantly reduce postoperative spotting. J Minim Invasive Gynecol. 2011;18:81–4. https://doi.org/10.1016/j.jmig.2010.09.014.

    Article  PubMed  Google Scholar 

  40. Zhang K, Jiang J-H, Hu J-L, Liu Y-L, Zhang X-H, Wang Y-M, et al. Large pelvic mass arising from the cervical stump: a case report. World J Clin Cases. 2020;8:149–56. https://doi.org/10.12998/wjcc.v8.i1.149.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Zhiqiang L, Bin S, Min F, Yufang L. Leiomyosarcoma of cervical stump following subtotal hysterectomy: a case report and review of literature. Eur J Gynaecol Oncol. 2016;37:148–51.

    PubMed  Google Scholar 

  42. Hall T, Lee SI, Boruta DM, Goodman A. Medical device safety and surgical dissemination of unrecognized uterine malignancy: morcellation in minimally invasive gynecologic surgery. Oncologist. 2015;20:1274–82. https://doi.org/10.1634/theoncologist.2015-0061.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Yoo E-H, Lee PI, Huh C-Y, Kim D-H, Lee B-S, Lee J-K, et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol. 2007;14:690–7. https://doi.org/10.1016/j.jmig.2007.06.003.

    Article  PubMed  Google Scholar 

  44. Shin DG, Yoo HJ, Lee YA, Kwon IS, Lee KH. Recurrence factors and reproductive outcomes of laparoscopic myomectomy and minilaparotomic myomectomy for uterine leiomyomas. Obstet Gynecol Sci. 2017;60:193–9. https://doi.org/10.5468/ogs.2017.60.2.193.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Radosa MP, Owsianowski Z, Mothes A, Weisheit A, Vorwergk J, Asskaryar FA, et al. Long-term risk of fibroid recurrence after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2014;180:35–9. https://doi.org/10.1016/j.ejogrb.2014.05.029.

    Article  PubMed  CAS  Google Scholar 

  46. Nezhat FR, Roemisch M, Nezhat CH, Seidman DS, Nezhat CR. Recurrence rate after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1998;5:237–40. https://doi.org/10.1016/s1074-3804(98)80025-x.

    Article  PubMed  CAS  Google Scholar 

  47. Fedele L, Parazzini F, Luchini L, Mezzopane R, Tozzi L, Villa L. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod. 1995;10:1795–6. https://doi.org/10.1093/oxfordjournals.humrep.a136176.

    Article  PubMed  CAS  Google Scholar 

  48. Rossetti A, Sizzi O, Soranna L, Cucinelli F, Mancuso S, Lanzone A. Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod. 2001;16:770–4. https://doi.org/10.1093/humrep/16.4.770.

    Article  PubMed  CAS  Google Scholar 

  49. Singh SS, Belland L. Contemporary management of uterine fibroids: focus on emerging medical treatments. Curr Med Res Opin. 2015;31:1–12. https://doi.org/10.1185/03007995.2014.982246.

    Article  PubMed  CAS  Google Scholar 

  50. Kotani Y, Tobiume T, Fujishima R, Shigeta M, Takaya H, Nakai H, et al. Recurrence of uterine myoma after myomectomy: open myomectomy versus laparoscopic myomectomy. J Obstet Gynaecol Res. 2018;44:298–302. https://doi.org/10.1111/jog.13519.

    Article  PubMed  Google Scholar 

  51. Reed SD, Newton KM, Thompson LB, McCrummen BA, Warolin AK. The incidence of repeat uterine surgery following myomectomy. J Womens Health (Larchmt). 2006;15:1046–52. https://doi.org/10.1089/jwh.2006.15.1046.

    Article  PubMed  Google Scholar 

  52. Pratt JH, Jefferies JA. The retained cervical stump. A 25-year experience. Obstet Gynecol. 1976;48:711–5.

    PubMed  CAS  Google Scholar 

  53. Neis F, Reisenauer C, Kraemer B, Wagner P, Brucker S. Retrospective analysis of secondary resection of the cervical stump after subtotal hysterectomy: why and when? Arch Gynecol Obstet. 2021;304:1519–26. https://doi.org/10.1007/s00404-021-06193-6.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Hilger WS, Pizarro AR, Magrina JF. Removal of the retained cervical stump. Am J Obstet Gynecol. 2005;193:2117–21. https://doi.org/10.1016/j.ajog.2005.07.015.

    Article  PubMed  Google Scholar 

  55. Tien C-T, Ding D-C. Adenomyoma recurrence 7 years after laparoscopic supracervical hysterectomy: a case report and literature review. Med (Baltim). 2023;102:e36089. https://doi.org/10.1097/MD.0000000000036089.

    Article  Google Scholar 

  56. Beck MM, Biswas B, D’Souza A, Kumar R. Benign metastasising leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Hong Kong Med J. 2012;18:153–5.

    PubMed  Google Scholar 

  57. Awonuga AO, Rotas M, Imudia AN, Choi C, Khulpateea N. Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Arch Gynecol Obstet. 2008;278:373–6. https://doi.org/10.1007/s00404-008-0581-z.

    Article  PubMed  Google Scholar 

  58. Kyriakopoulos K, Domali E, Stavrou S, Rodolakis A, Loutradis D, Drakakis P. Recurrent benign leiomyomas after total abdominal hysterectomy. Rich or poor estrogenic environment may lead to their recurrence? Int J Surg Case Rep. 2018;44:191–3. https://doi.org/10.1016/j.ijscr.2018.02.029.

    Article  PubMed  PubMed Central  Google Scholar 

  59. KRISHNAMOORTHY JK. Recurrent huge leiomyoma from the cervical stump-a rare case report. Univ J Surg Surg Specialities. 2018;4(4).

  60. Mathew SD, Abraham B. Cervical stump Fibroidpost Supra-cervical hysterectomy. Int J Health Sci. 2018;6(2):97–9.

    Google Scholar 

  61. Pelosi MA, Pelosi MA, Rudelli RD. Symptomatic cervical macrocyst as a late complication of subtotal hysterectomy. A case report. J Reprod Med. 1999;44:567–70.

    PubMed  Google Scholar 

  62. Barnard WG. Recurrence of Leio-Myo-sarcoma of the Uterus in the cervical stump. Proc R Soc Med. 1928;21:538.

    PubMed  PubMed Central  CAS  Google Scholar 

  63. Sturdy DE. Leiomyosarcoma of cervical stump following subtotal hysterectomy. Br J Surg. 1959;46:369–70. https://doi.org/10.1002/bjs.18004619812.

    Article  PubMed  CAS  Google Scholar 

  64. Lethaby A, Mukhopadhyay A, Naik R. Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst Rev. 2012;CD004993. https://doi.org/10.1002/14651858.CD004993.pub3.

  65. Giles AE. Large fibroid of Cervix developing after Subtotal Hysterectomy. Proc R Soc Med. 1923;16:12–3.

    PubMed  PubMed Central  CAS  Google Scholar 

  66. Fuchs IB, Henrich W, Schmider A, Lichtenegger W. Endometriotic cyst after subtotal abdominal hysterectomy mimicking carcinoma of the cervical stump. BJOG. 2003;110:637–8.

    Article  PubMed  Google Scholar 

  67. Hilger WS, Magrina JF. Removal of pelvic leiomyomata and endometriosis five years after supracervical hysterectomy. Obstet Gynecol. 2006;108:772–4. https://doi.org/10.1097/01.AOG.0000209187.90019.d3.

    Article  PubMed  Google Scholar 

  68. Yanamandra SR, Redman CWE, Coomarasamy A, Varma R. Leiomyoma appearing in the vaginal vault following hysterectomy. J Obstet Gynaecol. 2007;27:91–2. https://doi.org/10.1080/01443610601076176.

    Article  PubMed  CAS  Google Scholar 

  69. Ismail SMF, Adams SA. Vaginal vault leiomyoma. J Obstet Gynaecol. 2009;29:160–1. https://doi.org/10.1080/01443610802643972.

    Article  PubMed  CAS  Google Scholar 

  70. Yarci A, Bayramov V, Sükür YE, Yüce T, Berker B. Vaginal vault leiomyoma: 25 years after total abdominal hysterectomy. J Minim Invasive Gynecol. 2010;17:116–7. https://doi.org/10.1016/j.jmig.2009.10.004.

    Article  PubMed  Google Scholar 

  71. Guraslan H, Senturk MB, Helvacioglu C, Aktas AG, Yasar L. Recurrent cellular leiomyoma 10 years after total abdominal hysterectomy. J Obstet Gynaecol. 2015;35:854–5. https://doi.org/10.3109/01443615.2015.1009421.

    Article  PubMed  CAS  Google Scholar 

  72. Sezgin B, Camuzcuoğlu A, Camuzcuoğlu H. Laparoscopic removal of the cervical stump for a cervical solid mass in a patient with previous supracervical hysterectomy. J Turk Ger Gynecol Assoc. 2021;22:153–4. https://doi.org/10.4274/jtgga.galenos.2019.2019.0143.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the effort of the gynecology and anesthesia teams in El-shatby University Hospital, Alexandria, Egypt.

Funding

The authors have received no external funding.

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Alexandria, Egypt

    Ahmed Shoukry & Mahmoud Yousri

Authors
  1. Ahmed Shoukry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahmoud Yousri
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Ahmed Shoukry (AS) was the main surgeon and wrote the manuscript. Mahmoud Yousri (MS) was the main surgical assistant, read, revised, and approved the final manuscript.

Corresponding author

Correspondence to Ahmed Shoukry.

Ethics declarations

Consent to publish

Written informed consent was obtained from the patient for publication of this case report.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shoukry, A., Yousri, M. Cervical stump leiomyomata after supracervical hysterectomy; a case report with review of literature. BMC Women's Health 24, 500 (2024). https://doi.org/10.1186/s12905-024-03326-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-024-03326-2

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us